Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Cash from Investing Activities (2019 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Cash from Investing Activities for 13 consecutive years, with $27.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 157.52% to $27.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.3 million through Dec 2025, up 111.78% year-over-year, with the annual reading at $32.3 million for FY2025, 111.78% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $27.6 million at Madrigal Pharmaceuticals, up from -$207.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $163.9 million in Q1 2025, with the low at -$362.1 million in Q4 2023.
  • Average Cash from Investing Activities over 5 years is -$27.1 million, with a median of $17.4 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities skyrocketed 426.03% in 2021, then plummeted 3171.65% in 2024.
  • Over 5 years, Cash from Investing Activities stood at $15.6 million in 2021, then surged by 324.39% to $66.4 million in 2022, then tumbled by 645.47% to -$362.1 million in 2023, then soared by 86.76% to -$47.9 million in 2024, then skyrocketed by 157.52% to $27.6 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $27.6 million, -$207.0 million, and $47.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.